✨ Health and Trade Notices
NEW ZEALAND GAZETTE, No. 40 — 5 MAY 2016
a. where submissions on this application are to be sent; and
b. where requests for copies of the public information relating to the application can be sent; and
c. where public information relating to the application can be viewed; and
d. the director-general’s address for service:
ACVM Group, Ministry for Primary Industries, Pastoral House, 25 The Terrace, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140.
The applicant’s address for service is:
Schering-Plough Animal Health Limited, 33 Whakatiki Street, Upper Hutt 5018. Postal Address: Private Bag 908, Upper Hutt 5140.
Dated at Wellington this 3rd day of May 2016.
MAREE ZINZLEY, Manager Approvals Operations, Ministry for Primary Industries (acting under delegated authority).
2016-go2541
Approval of Pegasus Health GP Care Opioid Substitution Treatment and Clinician to Provide Substitution Treatment Under Section 24 of the Misuse of Drugs Act 1975
Pursuant to section 24(7)(b) of the Misuse of Drugs Act 1975, I, Anthony Duncan, acting under delegated authority from the Minister of Health, specify the Pegasus Health GP Care Opioid Substitution Treatment (“Pegasus Health GP Care OST”) as a service that may provide treatment with controlled drugs for people who are dependent on controlled drugs at the following place:
Pegasus Health
160 Bealey Avenue
Christchurch 8013
And, pursuant to section 24(7)(a) of the Misuse of Drugs Act 1975, acting under delegated authority from the Minister of Health, I specify
Dr Paul Hercock
as a medical practitioner, may:
a. prescribe, administer or supply controlled drugs for the treatment of dependence to controlled drugs as the lead clinician for Pegasus Health GP Care OST;
b. authorise in writing medical practitioners as specified under subsection (2)(b) to:
i. prescribe, administer or supply controlled drugs for the treatment of dependence;
ii. authorise in writing general practitioners receiving clients from Pegasus Health GP Care OST as specified under subsection (2)(d); and
c. authorise in writing general practitioners receiving clients from Pegasus Health GP Care OST as specified under subsection (2)(d).
Conditions
-
Controlled drugs may only be prescribed, administered or supplied to people who are or have been clients of Pegasus Health GP Care Opioid Substitution Treatment (OST) or Christchurch Opioid Recovery Service.
-
This approval expires on 31 December 2017.
Dated at Wellington this 2nd day of May 2016.
DR ANTHONY DUNCAN, Acting Deputy Director of Mental Health.
2016-go2545
Revocation of Notices Under Section 24 of the Misuse of Drugs Act 1975
Pursuant to section 24(7) of the Misuse of Drugs Act 1975, I, Anthony Duncan, acting under delegated authority from the Minister of Health, revoke the approval of the Pegasus Health GP Care Opioid Substitution Treatment
Next Page →
NZ Gazette 2016, No 40
✨ LLM interpretation of page content
🌾
Notice of Application to Register a Trade Name Product (Notice No. MPI 625)
(continued from previous page)
🌾 Primary Industries & Resources3 May 2016
Trade Name Registration, Agricultural Compounds, Veterinary Medicines, MPI, Mastiplan
- Maree Zinzley, Manager Approvals Operations, Ministry for Primary Industries
🏥 Approval of Pegasus Health GP Care Opioid Substitution Treatment
🏥 Health & Social Welfare2 May 2016
Opioid Substitution Treatment, Controlled Drugs, Misuse of Drugs Act, Pegasus Health, Christchurch
- Paul Hercock (Dr), Authorised to prescribe controlled drugs
- Anthony Duncan, Acting Deputy Director of Mental Health
🏥 Revocation of Notices Under Section 24 of the Misuse of Drugs Act 1975
🏥 Health & Social Welfare2 May 2016
Revocation, Opioid Substitution Treatment, Misuse of Drugs Act, Pegasus Health
- Anthony Duncan, Acting Deputy Director of Mental Health